Mary Glass

1.9k total citations
9 papers, 1.6k citations indexed

About

Mary Glass is a scholar working on Oncology, Immunology and Allergy and Immunology. According to data from OpenAlex, Mary Glass has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and Allergy and 4 papers in Immunology. Recurrent topics in Mary Glass's work include Cell Adhesion Molecules Research (5 papers), Chemokine receptors and signaling (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Mary Glass is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Chemokine receptors and signaling (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Mary Glass collaborates with scholars based in United States and Ireland. Mary Glass's co-authors include Douglas A. Arenberg, Robert M. Strieter, S. B. MORRIS, Marie D. Burdick, Mark D. Iannettoni, Peter J. Polverini, S L Kunkel, Richard I. Whyte, Bruno DiGiovine and M D Burdick and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Mary Glass

9 papers receiving 1.5k citations

Peers

Countries citing papers authored by Mary Glass

Since Specialization

Citations

This map shows the geographic impact of Mary Glass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Glass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Glass more than expected).

Fields of papers citing papers by Mary Glass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Glass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Glass. The network helps show where Mary Glass may publish in the future.

Co-authorship network of co-authors of Mary Glass

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Glass. A scholar is included among the top collaborators of Mary Glass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Glass. Mary Glass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Chronic IFNα treatment induces leukopoiesis, increased plasma succinate and immune cell metabolic rewiring 2023 ·Cellular Immunology ·(unknown), (unknown), Mary Glass, (unknown), Joseph Keane, Massimiliano Bianchi, Gina Leisching	4
2	CXC Chemokines Regulate Angiogenic Activity in Acute Lung Injury 1999 ·CHEST Journal ·Michael P. Keane, Carol A. Wilke, Marie D. Burdick, S. B. MORRIS, Mary Glass, Robert M. Strieter	5
3	Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells 1999 ·American Journal Of Pathology ·Bethany B. Moore, Douglas A. Arenberg, (unknown), Todd M. Morgan, Christina Addison, S. B. MORRIS, Mary Glass, Carol A. Wilke, Ying Xue, Stephanie Sitterding, Steven L. Kunkel, Marie D. Burdick, Robert M. Strieter	163
4	Differential regulation of C‐C chemokines during fibroblast‐monocyte interactions: adhesion vs. inflammatory cytokine pathways 1998 ·Mediators of Inflammation ·(unknown), S L Kunkel, K.J. Simpson, Holly Evanoff, Mary Glass, Robert M. Strieter, Nicholas W. Lukacs	23
5	Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. 1998 ·Journal of Clinical Investigation ·Douglas A. Arenberg, Michael P. Keane, Bruno DiGiovine, Steven L. Kunkel, S. B. MORRIS, Ying Xue, Marie D. Burdick, Mary Glass, Mark D. Iannettoni, Robert M. Strieter	224
6	The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis 1997 ·The Journal of Immunology ·Michael P. Keane, Douglas A. Arenberg, Joseph P. Lynch, Richard I. Whyte, Mark D. Iannettoni, Marie D. Burdick, Carol A. Wilke, S. B. MORRIS, Mary Glass, Bruno DiGiovine, Steven L. Kunkel, Robert M. Strieter	314
7	Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. 1996 ·Journal of Clinical Investigation ·Douglas A. Arenberg, S L Kunkel, Peter J. Polverini, Mary Glass, M D Burdick, Robert M. Strieter	347
8	Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8 1996 ·The Journal of Immunology ·Bruno DiGiovine, Joseph P. Lynch, F.J. Martinez, Andrew Flint, Richard I. Whyte, Mark D. Iannettoni, Douglas A. Arenberg, Marie D. Burdick, Mary Glass, Carol A. Wilke, S. B. MORRIS, S L Kunkel, R M Strieter	194
9	Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. 1996 ·The Journal of Experimental Medicine ·Douglas A. Arenberg, S L Kunkel, Peter J. Polverini, S. B. MORRIS, Marie D. Burdick, Mary Glass, (unknown), Mark D. Iannettoni, Richard I. Whyte, Robert M. Strieter	298

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact